Zelandopam (anhydrous)
Zelandopam (YM435) anhydrous is an orally active and selective agonist of the dopamine D1 receptor. Zelandopam anhydrous possesses potent renal vasodilatory properties and can effectively alleviate Cisplatin (HY-17394) -induced acute renal failure[1].
Product Specifications
CAS Number
[138086-00-7]
Product Name Alternative
YM435 (anhydrous)
UNSPSC
12352005
Target
Dopamine Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Smiles
OC1=C2C([C@H](C3=CC(O)=C(C=C3)O)CNC2)=CC=C1O.Cl
Molecular Formula
C15H16ClNO4
Molecular Weight
309.74
References & Citations
[1]Yatsu T, et al. Preventive effect of zelandopam, a dopamine D1 receptor agonist, on cisplatin-induced acute renal failure in rats[J]. European journal of pharmacology, 2003, 461 (2-3) : 191-195.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
